Metabolomic in Critical Ill Patients

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01506674

Enrollment

Registered

2012-01-10

Start date

2015-01-27

Completion date

2023-04-06

Last updated

2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolomic

Brief summary

Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 99 Years

Healthy volunteers

Inclusion criteria

* patients with severe left or right ventricular dysfunction undergoing cardiac surgery * patients undergoing ablation of ventricular tachycardia * patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases * patients undergoing thoracoabdominal vascular surgery

Exclusion criteria

* pregnant women * no written consent

Design outcomes

Primary

Measure	Time frame
Metabolomic patterns to identify poor outcome	hospital stay (approximately two weeks)

Countries

Italy

Outcome results